These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

332 related items for PubMed ID: 15539641

  • 1. Adenosine A2A receptor and dopamine D3 receptor interactions: evidence of functional A2A/D3 heteromeric complexes.
    Torvinen M, Marcellino D, Canals M, Agnati LF, Lluis C, Franco R, Fuxe K.
    Mol Pharmacol; 2005 Feb; 67(2):400-7. PubMed ID: 15539641
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. On the existence of a possible A2A-D2-β-Arrestin2 complex: A2A agonist modulation of D2 agonist-induced β-arrestin2 recruitment.
    Borroto-Escuela DO, Romero-Fernandez W, Tarakanov AO, Ciruela F, Agnati LF, Fuxe K.
    J Mol Biol; 2011 Mar 11; 406(5):687-99. PubMed ID: 21256133
    [Abstract] [Full Text] [Related]

  • 5. A serine point mutation in the adenosine A2AR C-terminal tail reduces receptor heteromerization and allosteric modulation of the dopamine D2R.
    Borroto-Escuela DO, Marcellino D, Narvaez M, Flajolet M, Heintz N, Agnati L, Ciruela F, Fuxe K.
    Biochem Biophys Res Commun; 2010 Mar 26; 394(1):222-7. PubMed ID: 20197060
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Fluorescence studies reveal heterodimerization of dopamine D1 and D2 receptors in the plasma membrane.
    Dziedzicka-Wasylewska M, Faron-Górecka A, Andrecka J, Polit A, Kuśmider M, Wasylewski Z.
    Biochemistry; 2006 Jul 25; 45(29):8751-9. PubMed ID: 16846218
    [Abstract] [Full Text] [Related]

  • 9. Adenosine A(2A) receptors, dopamine D(2) receptors and their interactions in Parkinson's disease.
    Fuxe K, Marcellino D, Genedani S, Agnati L.
    Mov Disord; 2007 Oct 31; 22(14):1990-2017. PubMed ID: 17618524
    [Abstract] [Full Text] [Related]

  • 10. Microvesicle and tunneling nanotube mediated intercellular transfer of g-protein coupled receptors in cell cultures.
    Guescini M, Leo G, Genedani S, Carone C, Pederzoli F, Ciruela F, Guidolin D, Stocchi V, Mantuano M, Borroto-Escuela DO, Fuxe K, Agnati LF.
    Exp Cell Res; 2012 Mar 10; 318(5):603-13. PubMed ID: 22266577
    [Abstract] [Full Text] [Related]

  • 11. Increased desensitization of dopamine D₂ receptor-mediated response in the ventral tegmental area in the absence of adenosine A(2A) receptors.
    Al-Hasani R, Foster JD, Metaxas A, Ledent C, Hourani SM, Kitchen I, Chen Y.
    Neuroscience; 2011 Sep 08; 190():103-11. PubMed ID: 21669258
    [Abstract] [Full Text] [Related]

  • 12. Flow cytometry application for studies on adenosine A2A receptors expression.
    Wójcik T, Bereta M, Faron-Górecka A, Dziedzicka-Wasylewska M, Kieć-Kononowicz K.
    Acta Pol Pharm; 2008 Sep 08; 65(1):65-70. PubMed ID: 18536175
    [Abstract] [Full Text] [Related]

  • 13. Pharmacological characterisation and inhibitory effects of (2R,3R,4S,5R)-2-(6-amino-2-{[(1S)-2-hydroxy-1-(phenylmethyl)ethyl]amino}-9H-purin-9-yl)-5-(2-ethyl-2H-tetrazol-5-yl)tetrahydro-3,4-furandiol, a novel ligand that demonstrates both adenosine A(2A) receptor agonist and adenosine A(3) receptor antagonist activity.
    Bevan N, Butchers PR, Cousins R, Coates J, Edgar EV, Morrison V, Sheehan MJ, Reeves J, Wilson DJ.
    Eur J Pharmacol; 2007 Jun 14; 564(1-3):219-25. PubMed ID: 17382926
    [Abstract] [Full Text] [Related]

  • 14. Trafficking of adenosine A2A and dopamine D2 receptors.
    Torvinen M, Torri C, Tombesi A, Marcellino D, Watson S, Lluis C, Franco R, Fuxe K, Agnati LF.
    J Mol Neurosci; 2005 Jun 14; 25(2):191-200. PubMed ID: 15784967
    [Abstract] [Full Text] [Related]

  • 15. The human D2 dopamine receptor synergizes with the A2A adenosine receptor to stimulate adenylyl cyclase in PC12 cells.
    Kudlacek O, Just H, Korkhov VM, Vartian N, Klinger M, Pankevych H, Yang Q, Nanoff C, Freissmuth M, Boehm S.
    Neuropsychopharmacology; 2003 Jul 14; 28(7):1317-27. PubMed ID: 12784121
    [Abstract] [Full Text] [Related]

  • 16. Antagonistic cannabinoid CB1/dopamine D2 receptor interactions in striatal CB1/D2 heteromers. A combined neurochemical and behavioral analysis.
    Marcellino D, Carriba P, Filip M, Borgkvist A, Frankowska M, Bellido I, Tanganelli S, Müller CE, Fisone G, Lluis C, Agnati LF, Franco R, Fuxe K.
    Neuropharmacology; 2008 Apr 14; 54(5):815-23. PubMed ID: 18262573
    [Abstract] [Full Text] [Related]

  • 17. Adenosine A1 receptor-mediated inhibition of dopamine release from rat striatal slices is modulated by D1 dopamine receptors.
    O'Neill C, Nolan BJ, Macari A, O'Boyle KM, O'Connor JJ.
    Eur J Neurosci; 2007 Dec 14; 26(12):3421-8. PubMed ID: 18052983
    [Abstract] [Full Text] [Related]

  • 18. Upregulation of A2A adenosine receptors in platelets from patients affected by bipolar disorders under treatment with typical antipsychotics.
    Martini C, Tuscano D, Trincavelli ML, Cerrai E, Bianchi M, Ciapparelli A, Alessio L, Novelli L, Catena M, Lucacchini A, Cassano GB, Dell'Osso L.
    J Psychiatr Res; 2006 Feb 14; 40(1):81-8. PubMed ID: 16431220
    [Abstract] [Full Text] [Related]

  • 19. Adenosine A2A and dopamine D2 heteromeric receptor complexes and their function.
    Fuxe K, Ferré S, Canals M, Torvinen M, Terasmaa A, Marcellino D, Goldberg SR, Staines W, Jacobsen KX, Lluis C, Woods AS, Agnati LF, Franco R.
    J Mol Neurosci; 2005 Feb 14; 26(2-3):209-20. PubMed ID: 16012194
    [Abstract] [Full Text] [Related]

  • 20. Kinetic and functional properties of [3H]ZM241385, a high affinity antagonist for adenosine A2A receptors.
    Uustare A, Vonk A, Terasmaa A, Fuxe K, Rinken A.
    Life Sci; 2005 Feb 11; 76(13):1513-26. PubMed ID: 15680315
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.